Pharmaceuticals Research and Development, GlaxoSmithKline, Collegeville, PA 19426;
Pharmaceuticals Research and Development, GlaxoSmithKline, Collegeville, PA 19426.
J Immunol. 2019 Oct 1;203(7):1897-1908. doi: 10.4049/jimmunol.1900560. Epub 2019 Sep 4.
Sepsis is characterized as life-threatening organ dysfunction caused by a dysregulated host immune response to infection. The purpose of this investigation was to determine the differential effect of sepsis on innate versus adaptive immunity, in humans, by examining RNA expression in specific immune cell subsets, including monocytes/macrophages and CD4 and CD8 T cells. A second aim was to determine immunosuppressive mechanisms operative in sepsis that might be amenable to immunotherapy. Finally, we examined RNA expression in peripheral cells from critically ill nonseptic patients and from cancer patients to compare the unique immune response in these disorders with that occurring in sepsis. Monocytes, CD4 T cells, and CD8 T cells from septic patients, critically ill nonseptic patients, patients with metastatic colon cancer, and healthy controls were analyzed by RNA sequencing. Sepsis induced a marked phenotypic shift toward downregulation of multiple immune response pathways in monocytes suggesting that impaired innate immunity may be fundamental to the immunosuppression that characterizes the disorder. In the sepsis cohort, there was a much more pronounced effect on gene transcription in CD4 T cells than in CD8 T cells. Potential mediators of sepsis-induced immunosuppression included , , and , which were highly upregulated in multiple cell types. Multiple negative costimulatory molecules, including , , , and , were also highly upregulated in sepsis. Although cancer had much more profound effects on gene transcription in CD8 T cells, common immunosuppressive mechanisms were present in all disorders, suggesting that immunoadjuvant therapies that are effective in one disease may also be efficacious in the others.
败血症的特征是由宿主对感染的免疫反应失调引起的危及生命的器官功能障碍。本研究旨在通过检查特定免疫细胞亚群(包括单核细胞/巨噬细胞和 CD4 和 CD8 T 细胞)中的 RNA 表达,确定败血症对固有免疫与适应性免疫的差异影响。目的二是确定败血症中可能适合免疫治疗的免疫抑制机制。最后,我们检查了来自重症非败血症患者和癌症患者的外周细胞中的 RNA 表达,以比较这些疾病中独特的免疫反应与败血症中发生的反应。通过 RNA 测序分析败血症患者、重症非败血症患者、转移性结肠癌患者和健康对照者的单核细胞、CD4 T 细胞和 CD8 T 细胞。败血症诱导单核细胞中多个免疫反应途径的明显表型转变,表明固有免疫受损可能是该疾病免疫抑制的基础。在败血症组中,CD4 T 细胞的基因转录受到的影响比 CD8 T 细胞更为明显。败血症诱导免疫抑制的潜在介质包括、、和,它们在多种细胞类型中高度上调。多个负性共刺激分子,包括、、和,在败血症中也高度上调。尽管癌症对 CD8 T 细胞的基因转录有更深远的影响,但所有疾病中都存在共同的免疫抑制机制,这表明在一种疾病中有效的免疫佐剂疗法在其他疾病中也可能有效。